The most crucial limitation of our research was The lack to test a PD-one/PD-L1 inhibitor in combination with S and S+R resulting from unavailability of a rat cross reactive antibody. Nevertheless, we did show PD-L1 upregulation on- or article- treatment method with S and S+R consequently significantly addressing this limitation.This great site use